Neither dabigatran nor rivaroxaban was linked to increased GI bleeding compared with warfarin

被引：3
|
作者：
Koretz, Ronald L. [1 ]
机构：
[1] Olive View UCLA Med Ctr, Sylmar, CA 91342 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2015年 / 163卷 / 06期
关键词：
ORAL ANTICOAGULANTS; METAANALYSIS;
D O I：
10.7326/ACPJC-2015-163-6-013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 10 条
  • [1] Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban
    Charlton, Blake
    Adeboyeje, Gboyega
    Barron, John J.
    Grady, Deborah
    Shin, Jaekyu
    Redberg, Rita F.
    PLOS ONE, 2018, 13 (03):
  • [2] Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
    Abraham, Neena S.
    Singh, Sonal
    Alexander, G. Caleb
    Heien, Herbert
    Haas, Lindsey R.
    Crown, William
    Shah, Nilay D.
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
  • [3] A comparison of bleeding complications between warfarin, dabigatran, and rivaroxaban in patients undergoing cryoballoon ablation
    Snipelisky, David
    Ray, Jordan C.
    Ung, Ryan
    Duart, Melissa
    Kauffman, Christine
    Kusumoto, Fred
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2014, 41 (03) : 231 - 236
  • [4] Bleeding risk with dabigatran, rivaroxaban, warfarin, and antiplatelet agent in Asians with non-valvular atrial fibrillation
    Chan, Yi-Hsin
    Yeh, Yung-Hsin
    Tu, Hui-Tzu
    Kuo, Chi-Tai
    Chang, Shang-Hung
    Wu, Lung-Sheng
    Lee, Hsin-Fu
    See, Lai-Chu
    ONCOTARGET, 2017, 8 (58) : 98898 - 98917
  • [5] Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation
    Adeboyeje, Gboyega
    Sylwestrzak, Gosia
    Barron, John J.
    White, Jeff
    Rosenberg, Alan
    Abarca, Jacob
    Crawford, Geoffrey
    Redberg, Rita
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (09): : 968 - 978
  • [6] Meta-Analysis of Efficacy and Safety of Rivaroxaban Compared With Warfarin or Dabigatran in Patients Undergoing Catheter Ablation for Atrial Fibrillation
    Aryal, Madan Raj
    Ukaigwe, Anene
    Pandit, Anil
    Karmacharya, Paras
    Pradhan, Rajesh
    Mainali, Naba Raj
    Pathak, Ranjan
    Jalota, Leena
    Bhandari, Yashoda
    Donato, Anthony
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (04): : 577 - 582
  • [7] Risk of stroke/systemic embolism, major bleeding, and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States medicare population: updated analysis
    Amin, Alpesh
    Keshishian, Allison
    Hines, Dionne M.
    Dina, Oluwaseyi
    Le, Hannah
    Rosenblatt, Lisa
    Liu, Xianchen
    Zhang, Qisu
    Vo, Lien
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (12) : 2131 - 2140
  • [8] US cost-effectiveness analysis of apixaban compared with warfarin, dabigatran and rivaroxaban for nonvalvular atrial fibrillation, focusing on equal value of life years and health years in total
    Atreja, Nipun
    Johannesen, Kasper
    Subash, Rupesh
    Bektur, Carina
    Hagan, Melissa
    Hines, Dionne M.
    Dunnett, Iulia
    Stawowczyk, Ewa
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2025, 14 (01)
  • [9] Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin A propensity score matched analysis
    Lip, Gregory Y. H.
    Keshishian, Allison
    Kamble, Shital
    Pan, Xianying
    Mardekian, Jack
    Horblyuk, Ruslan
    Hamilton, Melissa
    THROMBOSIS AND HAEMOSTASIS, 2016, 116 (05) : 975 - 986
  • [10] Letter by Hjemdahl et al Regarding Article, "Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial"
    Hjemdahl, Paul
    Johnsson, Hans
    Wallen, N. Halan
    CIRCULATION, 2013, 127 (11) : E505 - E505
1